A major vaccine maker has warned that global warming is helping widen the spread of tick-borne encephalitis (TBE) and chikungunya, raising fresh concerns that diseases traditionally concentrated in specific regions could increasingly threaten populations in new parts of the world.
WASHINGTON: A blood test designed to detect signals from multiple types of cancer in a single sample is moving toward a major US regulatory test, with the US Food and Drug Administration (FDA) set to convene an expert advisory panel next month to review GRAIL's Galleri multi-cancer early detection test.
NEW YORK: Cholesterol management is entering a new phase as new lipid-lowering therapies and updated clinical guidelines are expanding the options for people who need to reduce low-density lipoprotein cholesterol (LDL-C), commonly known as "bad" cholesterol.
Pakistan has been listed among the countries facing the world's largest measles outbreaks, with 11,037 cases recorded during a six-month surveillance period, according to the latest global update published by the United States Centers for Disease Control and Prevention.
What if living to 150-or even 190-years became biologically possible? A new scientific study suggests that such extraordinary lifespans may not be entirely beyond the limits of human biology.
GENEVA: The World Health Organization (WHO) has issued a stark warning that the global cancer burden is on track to escalate dramatically, with annual new cancer cases projected to rise from 20.
KARACHI: Pakistani researchers have taken a significant step in homegrown medical technology innovation after the Intellectual Property Organization (IPO) Pakistan accepted the patent application for an artificial intelligence-powered wearable device designed to detect impending epileptic seizures and automatically administer medication.
A growing body of evidence suggests that today's young adults may be aging faster than previous generations-and scientists now believe this accelerated biological aging could be one of the key reasons behind the alarming global rise in early-onset cancers.
TEHRAN: Iranian scientists have developed an experimental next-generation mRNA vaccine candidate for breast cancer, marking an important advance in cancer immunotherapy aimed at harnessing the body's immune system to fight tumors more precisely.